General
Preferred name
GENISTEIN
Synonyms
Genestein ()
NPI 031L ()
BIO-300 ()
Genistein (NPI 031L) ()
Sophoricol ()
.alpha.-isosparteine, (-)- ()
Isosparteine, alpha- ()
.alpha.-sparteine ()
(-)-.alpha.-isosparteine ()
NPI-031L ()
Genisteine ()
Genisteine-alkaloid ()
.alpha.-isosparteine ()
FW-635I-2 ()
Sparteine l-.alpha.-isosparteine ()
Bonistein ()
NSC-366737 ()
4',5,7-trihydroxyisoflavone ()
.alpha.-isospartein ()
NSC-36586 ()
SIPI-807-1 ()
11-isosparteine ()
Genisteina ()
BIO 300 ()
Genistein-d4 ()
P&D ID
PD002146
CAS
446-72-0
187960-08-3
Tags
available
natural product
drug candidate
Drug indication
Menopause symptom
Prostate cancer
Metabolic syndrome
Drug Status
investigational
Max Phase
2.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Genistein is a phytochemical present in soy extract that has antioxidant, anti-inflammatory, and estrogenic effects.
(GtoPdb)
MOA
Genistein may inhibit cancer cell growth by blocking enzymes required for cell growth. ; ; Genistein may decrease cardiovascular risk in postmenopausal women by interacting with the nuclear estrogen receptors to alter the transcription of cell specific genes. In randomized clinical trials, genistein was seen to increase the ratio of nitric oxide to endothelin and improved flow-mediated endothelium dependent vasodilation in healthy postmenopausal women [A14417]. In addition, genistein may have beneficial effects on glucose metabolism by inhibiting islet tyrosine kinase activity as well as insulin release dependent on glucose and sulfonylurea [A14417].
PRICE
29
DESCRIPTION
Genistein, a soy isoflavone, is a multiple tyrosine kinases (e.g., EGFR) inhibitor which acts as a chemotherapeutic agent against different types of cancer, mainly by altering apoptosis, the cell cycle, and angiogenesis and inhibiting metastasis.
DESCRIPTION
Genistein is an isoflavonoid derived from soy products. It inhibits protein-tyrosine kinase and topoisomerase-II activity and is used as an antineoplastic and antitumor agent.
(Enamine Bioactive Compounds)
DESCRIPTION
Non-selective PI 3-kinase inhibitor
(Tocris Bioactive Compound Library)
DESCRIPTION
EGFR kinase inhibitor. Also estrogen and PPARgamma ligand
(Tocriscreen Plus)
DESCRIPTION
Cytotoxic inhibitor of tyrosine kinase and topoisomerase II kinase
(LOPAC library)
DESCRIPTION
EGFR kinase inhibitor. Also estrogen and PPARγ ligand
(Tocriscreen Total)
DESCRIPTION
Genistein (NPI 031L) is a naturally occurring soy isoflavone, a multi-targeted tyrosine kinase inhibitor. Genistein has antitumor, antioxidant, and anthelmintic properties, and also produces estrogen-like effects in the body.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
72
Organisms
9
Compound Sets
29
A Collection of Useful Nuisance Compounds (CONS) for Interrogation of Bioassay Integrity
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Concise Guide to Pharmacology 2025/26
CZ-OPENSCREEN Bioactive Library
Drug Repurposing Hub
DrugBank
DrugMAP
DrugMatrix
Enamine Bioactive Compounds
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
IPPI - DB
LOPAC library
MedChem Express Bioactive Compound Library
NPC Screening Collection
Nuisance compounds in cellular assays
NURSA ligand set
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
Tocris Bioactive Compound Library
Tocriscreen Plus
Tocriscreen Total
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
273
Molecular Weight
270.05
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
3
Rotatable Bonds
1
Ring Count
3
Aromatic Ring Count
3
cLogP
2.58
TPSA
90.9
Fraction CSP3
0.0
Chiral centers
0.0
Largest ring
6.0
QED
0.63
Structural alerts
2
Phenol
Nuisance compounds
Nonspecific/NOS
Flavonoid
Nuisance compounds
Custom attributes
(extracted from source data)
Target Type
Enzyme-Linked Receptors
Selectivity
Tyrosine kinase
Pathway
Angiogenesis
Apoptosis
Autophagy
JAK/STAT Signaling
Metabolism
Tyrosine Kinase/Adaptors
Metabolic Enzyme/Protease
Protein Tyrosine Kinase/RTK
Primary Target
EGFR
MOA
Inhibitor
tyrosine kinase inhibitor
Target
CFTR, ESR1, ESR2, ESRRA, ESRRB, ESRRG, NCOA1, NCOA2, PPARG, PTK2B, TOP2A, TRPC5
EGFR,Topoisomerase
Endogenous Metabolite
Nuisance MOA
Phenol
Targets
Estrogen receptor beta
Estrogen receptor alpha
Estrogen-related receptor alpha
Source data

